Home Cart Sign in  
Chemical Structure| 522629-08-9 Chemical Structure| 522629-08-9
Chemical Structure| 522629-08-9

CGP 57380

CAS No.: 522629-08-9

CGP-57380 is a selective Mnk1 inhibitor with IC50 value of 2.2 μM.

Synonyms: MNK1 Inhibitor

4.5 *For Research Use Only !

Cat. No.: A151588 Purity: 99% (HPLC)

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łËď¶ÊÊ Inquiry Inquiry
5mg łò˶ÊÊ Inquiry Inquiry
10mg łîǶÊÊ Inquiry Inquiry
25mg łÇÿÿ¶ÊÊ Inquiry Inquiry
50mg łËò§¶ÊÊ Inquiry Inquiry
100mg łÍÍͶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łËď¶ÊÊ

  • 5mg

    łò˶ÊÊ

  • 10mg

    łîǶÊÊ

  • 25mg

    łÇÿÿ¶ÊÊ

  • 50mg

    łËò§¶ÊÊ

  • 100mg

    łÍÍͶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of CGP 57380

CAS No. :522629-08-9
Formula : C11H9FN6
M.W : 244.23
SMILES Code : NC1=C2C(NN=C2NC3=CC=C(F)C=C3)=NC=N1
Synonyms :
MNK1 Inhibitor
MDL No. :MFCD03861062
InChI Key :UQPMANVRZYYQMD-UHFFFAOYSA-N
Pubchem ID :11644425

Safety of CGP 57380

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Related Pathways of CGP 57380

MAPK

Isoform Comparison

Biological Activity

Target
  • MNK1

    MNK1, IC50:2.2 μM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
CNE1 38.261 µM 72 h Inhibition of cell proliferation and colony formation ability PMC5485425
NP69 273.44 µM 72 h Low toxicity to normal cells PMC5485425
HNE1 103.278 µM 72 h Inhibition of cell proliferation and colony formation ability PMC5485425
U87MG-luc cells 10 μM 3 days MTT assay showed that combined treatment with CGP57380 and RAD001 significantly inhibited cell proliferation. PMC3904612
LN229 cells 10 μM 20 h Western blot analysis showed that CGP57380 or MNK1 siRNA combined with RAD001 significantly inhibited 4EBP1 phosphorylation at Ser65. PMC3904612
U373 cells 10 μM 20 h Analyzed how MNK1 and mTORC1 signaling pathways regulate the assembly of translation initiation complexes, found that CGP57380 or MNK1 knockdown combined with RAD001 increased 4EBP1 binding to eIF4E. PMC3904612
CEM cells 4-16 μM 24 h CGP57380 dose-dependently suppressed the expression of both phosphor-MNK1 and phosphor-eIF4E, thereby inhibiting downstream targets such as c-Myc and survivin. PMC6289382
Jurkat cells 4-16 μM 24 h CGP57380 dose-dependently suppressed the expression of both phosphor-MNK1 and phosphor-eIF4E, thereby inhibiting downstream targets such as c-Myc and survivin. PMC6289382
A549 cells 20 μM CGP57380 substantially reduced eIF4G in the eIF4F complex while drastically inhibiting eIF4E phosphorylation PMC2950334
H157 cells 10-40 μM 30 min CGP57380 reduced basal p-eIF4E levels and almost completely blocked OA-induced increase in eIF4E phosphorylation PMC2950334

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Nude mice Orthotopic GBM mouse model I.p. injection 25 mg/kg 4 injections between days 8 and 15 after implantation Evaluated the effects of CGP57380 alone or in combination with RAD001 in vivo, found that combined treatment significantly inhibited tumor growth. PMC3904612
BALB/c nude mice Subcutaneous tumor model Intraperitoneal injection 25 mg/kg Three times per week for 3 weeks Inhibition of tumor growth and metastasis PMC5485425
C57BL/6 mice LPS-induced acute lung injury model Intraperitoneal injection 30 mg/kg Single dose, pretreated for 30 min before LPS challenge To evaluate the protective effect of CGP57380 on LPS-induced acute lung injury. Results showed that CGP57380 pretreatment significantly attenuated LPS-induced lung wetry ratio, protein content, total cells and neutrophils in BALF, and decreased the production of pro-inflammatory mediators such as IL-6, TNF-α, and KC. PMC7957947
Sprague-Dawley rats Experimental model of brain stem death Bilateral microinjection into RVLM 5 pmol Single administration, observed for 180 minutes To evaluate the effect of CGP57380 on cardiovascular regulation in the brain stem death model. Results showed that CGP57380 pretreatment exacerbated hypotension and blunted the life signal, shortening the pro-life phase. PMC2848001

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.09mL

0.82mL

0.41mL

20.47mL

4.09mL

2.05mL

40.95mL

8.19mL

4.09mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories